
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
Esmé Waanders, Zhaohui Gu, Stephanie M. Dobson, et al.
Blood Cancer Discovery (2020) Vol. 1, Iss. 1, pp. 96-111
Open Access | Times Cited: 114
Esmé Waanders, Zhaohui Gu, Stephanie M. Dobson, et al.
Blood Cancer Discovery (2020) Vol. 1, Iss. 1, pp. 96-111
Open Access | Times Cited: 114
Showing 1-25 of 114 citing articles:
Pediatric acute lymphoblastic leukemia
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
Anita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Cancer (2022) Vol. 4, Iss. 2, pp. 203-221
Open Access | Times Cited: 76
Anita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Cancer (2022) Vol. 4, Iss. 2, pp. 203-221
Open Access | Times Cited: 76
Advances in germline predisposition to acute leukaemias and myeloid neoplasms
Jeffery M. Klco, Charles G. Mullighan
Nature reviews. Cancer (2020) Vol. 21, Iss. 2, pp. 122-137
Open Access | Times Cited: 123
Jeffery M. Klco, Charles G. Mullighan
Nature reviews. Cancer (2020) Vol. 21, Iss. 2, pp. 122-137
Open Access | Times Cited: 123
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 102
Valentina Cordoʹ, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, et al.
Blood Cancer Discovery (2020) Vol. 2, Iss. 1, pp. 19-31
Open Access | Times Cited: 102
The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities
Thai Hoa Tran, Stephen P. Hunger
Seminars in Cancer Biology (2020) Vol. 84, pp. 144-152
Closed Access | Times Cited: 92
Thai Hoa Tran, Stephen P. Hunger
Seminars in Cancer Biology (2020) Vol. 84, pp. 144-152
Closed Access | Times Cited: 92
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs
Stephanie M. Dobson, Laura García‐Prat, Robert Vanner, et al.
Cancer Discovery (2020) Vol. 10, Iss. 4, pp. 568-587
Open Access | Times Cited: 85
Stephanie M. Dobson, Laura García‐Prat, Robert Vanner, et al.
Cancer Discovery (2020) Vol. 10, Iss. 4, pp. 568-587
Open Access | Times Cited: 85
MOLECULAR PROFILING REVEALS NOVEL GENE FUSIONS AND GENETIC MARKERS FOR REFINED PATIENT STRATIFICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
Borbála Péterffy, Szilvia Krizsán, Bálint Egyed, et al.
Modern Pathology (2025), pp. 100741-100741
Open Access | Times Cited: 1
Borbála Péterffy, Szilvia Krizsán, Bálint Egyed, et al.
Modern Pathology (2025), pp. 100741-100741
Open Access | Times Cited: 1
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Jason R. Schwartz, Jing Ma, Jennifer L. Kamens, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Jason R. Schwartz, Jing Ma, Jennifer L. Kamens, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
Daniel Leongamornlert, Jesús Gutiérrez‐Abril, SooWah Lee, et al.
Blood Advances (2023) Vol. 7, Iss. 15, pp. 3862-3873
Open Access | Times Cited: 17
Daniel Leongamornlert, Jesús Gutiérrez‐Abril, SooWah Lee, et al.
Blood Advances (2023) Vol. 7, Iss. 15, pp. 3862-3873
Open Access | Times Cited: 17
Molecular markers in ALL: Clinical implications
Shunsuke Kimura, Charles G. Mullighan
Best Practice & Research Clinical Haematology (2020) Vol. 33, Iss. 3, pp. 101193-101193
Open Access | Times Cited: 46
Shunsuke Kimura, Charles G. Mullighan
Best Practice & Research Clinical Haematology (2020) Vol. 33, Iss. 3, pp. 101193-101193
Open Access | Times Cited: 46
ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?
Kelly Féral, Manon Jaud, Céline Philippe, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 199-199
Open Access | Times Cited: 40
Kelly Féral, Manon Jaud, Céline Philippe, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 199-199
Open Access | Times Cited: 40
Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse
Fan Yang, Samuel W. Brady, Chao Tang, et al.
Nature Cancer (2021) Vol. 2, Iss. 8, pp. 819-834
Closed Access | Times Cited: 37
Fan Yang, Samuel W. Brady, Chao Tang, et al.
Nature Cancer (2021) Vol. 2, Iss. 8, pp. 819-834
Closed Access | Times Cited: 37
Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy
Chang Yang, Yu Jiang, Sai Heng Hao, et al.
Journal of Materials Chemistry B (2021) Vol. 10, Iss. 1, pp. 20-33
Closed Access | Times Cited: 34
Chang Yang, Yu Jiang, Sai Heng Hao, et al.
Journal of Materials Chemistry B (2021) Vol. 10, Iss. 1, pp. 20-33
Closed Access | Times Cited: 34
Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL
Lisa-Marie Vieler, Verena Nilius‐Eliliwi, Roland Schroers, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 686-686
Open Access | Times Cited: 15
Lisa-Marie Vieler, Verena Nilius‐Eliliwi, Roland Schroers, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 686-686
Open Access | Times Cited: 15
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy
Tim H. H. Coorens, Grace Collord, Taryn D. Treger, et al.
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1095-1101
Open Access | Times Cited: 14
Tim H. H. Coorens, Grace Collord, Taryn D. Treger, et al.
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1095-1101
Open Access | Times Cited: 14
SJPedPanel: A pan-cancer gene panel for childhood malignancies to enhance cancer monitoring and early detection
Pandurang Kolekar, Vidya Balagopal, Li Dong, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 4100-4114
Open Access | Times Cited: 5
Pandurang Kolekar, Vidya Balagopal, Li Dong, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 4100-4114
Open Access | Times Cited: 5
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies
Suguru Fukuhara, Yuji Oshikawa, Yasunori Kogure, et al.
Cancer Science (2022) Vol. 113, Iss. 8, pp. 2763-2777
Open Access | Times Cited: 20
Suguru Fukuhara, Yuji Oshikawa, Yasunori Kogure, et al.
Cancer Science (2022) Vol. 113, Iss. 8, pp. 2763-2777
Open Access | Times Cited: 20
ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia
Kirsten Dickerson, Chunxu Qu, Qingsong Gao, et al.
Blood Cancer Discovery (2022) Vol. 3, Iss. 3, pp. 240-263
Open Access | Times Cited: 19
Kirsten Dickerson, Chunxu Qu, Qingsong Gao, et al.
Blood Cancer Discovery (2022) Vol. 3, Iss. 3, pp. 240-263
Open Access | Times Cited: 19
Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights
Ilaria Iacobucci, Matthew T. Witkowski, Charles G. Mullighan
Blood (2022) Vol. 141, Iss. 4, pp. 356-368
Open Access | Times Cited: 19
Ilaria Iacobucci, Matthew T. Witkowski, Charles G. Mullighan
Blood (2022) Vol. 141, Iss. 4, pp. 356-368
Open Access | Times Cited: 19
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities
Yongfeng Chen, Jing Li, Linglong Xu, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 268-291
Open Access | Times Cited: 12
Yongfeng Chen, Jing Li, Linglong Xu, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 268-291
Open Access | Times Cited: 12
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia
Zhenhua Li, Huanbin Zhao, Wenjian Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Zhenhua Li, Huanbin Zhao, Wenjian Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies
Fatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Fatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Epigenetic Rewiring of Protein Kinase Signalling in T-Cell Acute Lymphoblastic Leukaemia
Claudina Pérez-Novo, Amber Driesen, Maaike Van Trimpont, et al.
Kinases and Phosphatases (2025) Vol. 3, Iss. 2, pp. 7-7
Open Access
Claudina Pérez-Novo, Amber Driesen, Maaike Van Trimpont, et al.
Kinases and Phosphatases (2025) Vol. 3, Iss. 2, pp. 7-7
Open Access
Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
Sarah Meyers, Llucia Albertí Servera, Olga Gielen, et al.
HemaSphere (2022) Vol. 6, Iss. 4, pp. e700-e700
Open Access | Times Cited: 18
Sarah Meyers, Llucia Albertí Servera, Olga Gielen, et al.
HemaSphere (2022) Vol. 6, Iss. 4, pp. e700-e700
Open Access | Times Cited: 18
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
María Agustina Perusini, Daniela Žáčková, Tae‐Hyung Kim, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2361-2372
Open Access | Times Cited: 3
María Agustina Perusini, Daniela Žáčková, Tae‐Hyung Kim, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2361-2372
Open Access | Times Cited: 3